Covidien, GI Solutions clinical trials
Acquired by Medtronic, Jan 26, 2015 · source ↗
The registry lists 2 studies whose lead sponsor is Covidien, GI Solutions. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 21, 2020.
Before and after it joined Medtronic
- First submitted before Covidien, GI Solutions became part of Medtronic
- 2
- First submitted after Covidien, GI Solutions became part of Medtronic
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Covidien, GI Solutions2 studies
Something wrong with this grouping? Tell us on the Medtronic page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Medtronic studies →
- Radiofrequency Ablation for Patients With Esophageal Squamous Cell NeoplasiaCompletedNCT02047305Not applicable
Sponsor listed in the registry: Covidien, GI Solutions · First submitted before Covidien, GI Solutions became part of Medtronic
- Micro-Layer Ablation of Barrett's Metaplasia- A Two-Phase, Multi-Center Trial - Extension of Follow-up to 5 YearsCompletedNCT00489268Not applicable
Sponsor listed in the registry: Covidien, GI Solutions · First submitted before Covidien, GI Solutions became part of Medtronic